Treatment schedule and estrogen receptor-status influence acquisition of doxorubicin resistance in breast cancer cells

Logeswari Ponnusamy, Prathap Kumar S Mahalingaiah, Kamaleshwar Singh

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)424-433
JournalEuropean J Pharmaceutical Sciences
StatePublished - Jun 15 2017

Fingerprint Dive into the research topics of 'Treatment schedule and estrogen receptor-status influence acquisition of doxorubicin resistance in breast cancer cells'. Together they form a unique fingerprint.

Cite this